A Study of the ReCor Medical Paradise System in Clinical Hypertension

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 282 participants.

Also called NCT02649426

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 282 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02649426
Other papers using this trial's data
  • Effects of Renal Denervation vs Sham in Resistant Hypertension After Medication Escalation: Prespecified Analysis at 6 Months of the RADIANCE-HTN TRIO Randomized Clinical Trial JAMA cardiology, 2022-12-01 DOI, PubMed 36350593, PMC9647563 In the PMC Open Access subset under CC BY-NC-ND.
  • Plasma renin and aldosterone concentrations related to endovascular ultrasound renal denervation in the RADIANCE-HTN SOLO trial Journal of hypertension, 2022-02-01 DOI, PubMed 34433763
  • Renal Artery Variations in Patients With Mild-to-Moderate Hypertension From the RADIANCE-HTN SOLO Trial Cardiovascular revascularization medicine : including molecular interventions, 2022-06 DOI, PubMed 34620570
  • Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial Lancet (London, England), 2021-06-26 DOI, PubMed 34010611

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Results first posted
(from the registry)
Countries
United States, Belgium, France, Germany, Netherlands, Poland, United Kingdom (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT02649426. Randomized; triple masking; primary purpose treatment. Start 2016-03 (actual); primary completion 2020-09 (actual). Results posted on 2024-06-28.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study of the ReCor Medical Paradise System in Clinical Hypertension
Acronym
RADIANCE-HTN
Condition
Hypertension
Condition
Vascular Diseases
Intervention (Device)
The Paradise® Renal Denervation Ultrasound System
Intervention (Device)
Sham Procedure
Lead sponsor
ReCor Medical, Inc. (class: industry)

Record details

Record id
cardio:ct-nct02649426
Content hash
c1667416bea6586d46d909b2688f285dc49227dcc5300d3bc0a0edd2721ff329